The total synthesis and biological properties of the cytotoxic macrolide FD-891 and its non-natural (Z)-C12 isomer. 2007

Jorge García-Fortanet, and Juan Murga, and Miguel Carda, and J Alberto Marco, and Ruth Matesanz, and J Fernando Díaz, and Isabel Barasoain
Depart. de Q. Inorgánica y Orgánica, Univ. Jaume I, Avda. Sos Baynat s/n, 12071 Castellón, Spain.

A total, stereoselective synthesis of the naturally occurring, cytotoxic macrolide FD-891 and of its non-natural (Z)-C12 isomer is described. Three fragments of the main carbon chain were stereoselectively prepared by using asymmetric aldol and allylation reactions as the key steps. The molecule was then assembled by using two Julia-Kocienski olefinations to connect the three fragments and a Yamaguchi reaction to close the macrolactone ring. Some specific biological properties (cytotoxicity, binding to tubulin) have been determined for both macrolides. The E configuration of the C12-C13 olefinic bond seems to be an important feature in determining the cytotoxicity but the precise biological mechanism of the latter still remains to be cleared.

UI MeSH Term Description Entries
D007536 Isomerism The phenomenon whereby certain chemical compounds have structures that are different although the compounds possess the same elemental composition. (From McGraw-Hill Dictionary of Scientific and Technical Terms, 5th ed) Isomerisms
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000447 Aldehydes Organic compounds containing a carbonyl group in the form -CHO. Aldehyde
D000475 Alkenes Unsaturated hydrocarbons of the type Cn-H2n, indicated by the suffix -ene. (Grant & Hackh's Chemical Dictionary, 5th ed, p408) Alkene,Olefin,Olefins,Pentene,Pentenes
D000498 Allyl Compounds Alkenes with the general formula H2C Compounds, Allyl
D000970 Antineoplastic Agents Substances that inhibit or prevent the proliferation of NEOPLASMS. Anticancer Agent,Antineoplastic,Antineoplastic Agent,Antineoplastic Drug,Antitumor Agent,Antitumor Drug,Cancer Chemotherapy Agent,Cancer Chemotherapy Drug,Anticancer Agents,Antineoplastic Drugs,Antineoplastics,Antitumor Agents,Antitumor Drugs,Cancer Chemotherapy Agents,Cancer Chemotherapy Drugs,Chemotherapeutic Anticancer Agents,Chemotherapeutic Anticancer Drug,Agent, Anticancer,Agent, Antineoplastic,Agent, Antitumor,Agent, Cancer Chemotherapy,Agents, Anticancer,Agents, Antineoplastic,Agents, Antitumor,Agents, Cancer Chemotherapy,Agents, Chemotherapeutic Anticancer,Chemotherapy Agent, Cancer,Chemotherapy Agents, Cancer,Chemotherapy Drug, Cancer,Chemotherapy Drugs, Cancer,Drug, Antineoplastic,Drug, Antitumor,Drug, Cancer Chemotherapy,Drug, Chemotherapeutic Anticancer,Drugs, Antineoplastic,Drugs, Antitumor,Drugs, Cancer Chemotherapy
D001665 Binding Sites The parts of a macromolecule that directly participate in its specific combination with another molecule. Combining Site,Binding Site,Combining Sites,Site, Binding,Site, Combining,Sites, Binding,Sites, Combining
D014404 Tubulin A microtubule subunit protein found in large quantities in mammalian brain. It has also been isolated from SPERM FLAGELLUM; CILIA; and other sources. Structurally, the protein is a dimer with a molecular weight of approximately 120,000 and a sedimentation coefficient of 5.8S. It binds to COLCHICINE; VINCRISTINE; and VINBLASTINE. alpha-Tubulin,beta-Tubulin,delta-Tubulin,epsilon-Tubulin,gamma-Tubulin,alpha Tubulin,beta Tubulin,delta Tubulin,epsilon Tubulin,gamma Tubulin
D045744 Cell Line, Tumor A cell line derived from cultured tumor cells. Tumor Cell Line,Cell Lines, Tumor,Line, Tumor Cell,Lines, Tumor Cell,Tumor Cell Lines
D018942 Macrolides A group of often glycosylated macrocyclic compounds formed by chain extension of multiple PROPIONATES cyclized into a large (typically 12, 14, or 16)-membered lactone. Macrolides belong to the POLYKETIDES class of natural products, and many members exhibit ANTIBIOTIC properties. Macrolide

Related Publications

Jorge García-Fortanet, and Juan Murga, and Miguel Carda, and J Alberto Marco, and Ruth Matesanz, and J Fernando Díaz, and Isabel Barasoain
December 2012, The Journal of organic chemistry,
Jorge García-Fortanet, and Juan Murga, and Miguel Carda, and J Alberto Marco, and Ruth Matesanz, and J Fernando Díaz, and Isabel Barasoain
March 2006, Journal of the American Chemical Society,
Jorge García-Fortanet, and Juan Murga, and Miguel Carda, and J Alberto Marco, and Ruth Matesanz, and J Fernando Díaz, and Isabel Barasoain
October 2014, Organic letters,
Jorge García-Fortanet, and Juan Murga, and Miguel Carda, and J Alberto Marco, and Ruth Matesanz, and J Fernando Díaz, and Isabel Barasoain
February 2004, The Journal of antibiotics,
Jorge García-Fortanet, and Juan Murga, and Miguel Carda, and J Alberto Marco, and Ruth Matesanz, and J Fernando Díaz, and Isabel Barasoain
May 2000, The Journal of organic chemistry,
Jorge García-Fortanet, and Juan Murga, and Miguel Carda, and J Alberto Marco, and Ruth Matesanz, and J Fernando Díaz, and Isabel Barasoain
April 2018, The Journal of organic chemistry,
Jorge García-Fortanet, and Juan Murga, and Miguel Carda, and J Alberto Marco, and Ruth Matesanz, and J Fernando Díaz, and Isabel Barasoain
August 2020, Journal of natural products,
Jorge García-Fortanet, and Juan Murga, and Miguel Carda, and J Alberto Marco, and Ruth Matesanz, and J Fernando Díaz, and Isabel Barasoain
October 2002, Angewandte Chemie (International ed. in English),
Jorge García-Fortanet, and Juan Murga, and Miguel Carda, and J Alberto Marco, and Ruth Matesanz, and J Fernando Díaz, and Isabel Barasoain
October 2002, Organic letters,
Jorge García-Fortanet, and Juan Murga, and Miguel Carda, and J Alberto Marco, and Ruth Matesanz, and J Fernando Díaz, and Isabel Barasoain
September 2009, The Journal of antibiotics,
Copied contents to your clipboard!